• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Sana Biotechnology, Inc. - Common Stock (NQ:SANA)

2.720 -0.030 (-1.09%)
Delayed Quote Updated: 4:00 PM EDT, Oct 7, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 4,315,445
Open 2.710
Bid (Size) 2.760 (100)
Ask (Size) 2.800 (2,600)
Prev. Close 2.750
Today's Range 2.700 - 2.845
52wk Range 2.610 - 6.550
Shares Outstanding 191,500,944
Dividend Yield N/A
Chart for  (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Replacing Insulin Cells Works. Keeping The Cells Alive Is the Trick
September 08, 2026
A look at the three approaches competing to help beta cell replacement survive the immune system 
From Biotech Insider
Via GlobeNewswire
News headline image
Sana Biotechnology to Present at September 2026 Investor Conferences
September 01, 2026
From Sana Biotechnology, Inc
Via GlobeNewswire

Performance

52-Week Range 58.5% below 52-week high
2.720
2.6152W Low 6.5552W High
1 Week 10.8% below 1-week high
2.701W Low 3.051W High

Sana Biotechnology, Inc. - Common Stock (SANA) traded between $2.61 and $6.55 over the past 52 weeks and last traded at $2.72, 58.5% below its 52-week high. Over the past week it ranged between $2.70 and $3.05.

Past 12 Months
-5.9%
-21.2%
-31.7%
-15.3%
-35.1%
-34.0%
1W -$0.17
1M -$0.73
3M -$1.26
6M -$0.49
YTD -$1.47
1Y -$1.40

SANA was -34.0% over the past year, -15.3% over six months, -35.1% year to date, -5.9% in the last week.

12 Months vs Market
SANA
-34.0%
DIA
+9.7%
SPY
+16.2%
QQQ
+25.3%
IWM
+13.7%

Over the past 12 months SANA returned -34.0% versus DIA (Dow) +9.7%, SPY (S&P 500) +16.2%, QQQ (Nasdaq 100) +25.3% and IWM (Russell 2000) +13.7%.

Volume & Liquidity 1.39× 3-mo avg
Today 4,315,445 3-mo avg 3.1M
1W
4.1M
1M
4.3M
3M
3.1M
6M
3.5M
YTD
3.2M
1Y
3.7M

SANA most recently traded 4,315,445 shares against a 3-month average daily volume of 3.1M.

More News

Read More
News headline image
Sana Biotechnology Reports Second Quarter 2026 Financial Results and Business Updates
August 10, 2026
From Sana Biotechnology, Inc
Via GlobeNewswire
News headline image
Sana Biotechnology Announces Follow-On Publication in The New England Journal of Medicine (NEJM) Highlighting Groundbreaking Long-Term Data and Durability of Hypoimmune-Modified Islet Cell Transplantation Without Immunosuppression in Type 1 Diabetes
July 13, 2026
From Sana Biotechnology, Inc
Via GlobeNewswire
News headline image
Sana Biotechnology Announces Symposium Presentation at the European Association for the Study of Diabetes (EASD) Annual Meeting 2026
July 01, 2026
From Sana Biotechnology, Inc
Via GlobeNewswire
News headline image
Sana Biotechnology to Present at June 2026 Investor Conferences
May 27, 2026
From Sana Biotechnology, Inc
Via GlobeNewswire
News headline image
Sana Biotechnology Announces Sale of Approximately $69 Million of Shares Through its At-the-Market (ATM) Facility
May 15, 2026
From Sana Biotechnology, Inc
Via GlobeNewswire
News headline image
Sana Biotechnology Reports First Quarter 2026 Financial Results and Business Updates
May 11, 2026
From Sana Biotechnology, Inc
Via GlobeNewswire
News headline image
Sana Biotechnology to Present at the BofA Securities 2026 Healthcare Conference
May 05, 2026
From Sana Biotechnology, Inc
Via GlobeNewswire
News headline image
Sana Biotechnology Announces Oral Presentation Highlighting Preclinical Data from in vivo CAR T SG293 at the American Society of Gene & Cell Therapy (ASGCT) 2026 Annual Meeting
April 27, 2026
From Sana Biotechnology, Inc
Via GlobeNewswire
News headline image
Peraso (NASDAQ: PRSO) Delivers Military Drone IFF Systems, Stock Sets Up for Potential Re-Coil
April 14, 2026
Via AB Newswire
News headline image
Reloading Alert: PRSO, SANA, ROLR, PMNT – Catalysts Align as Momentum Builds
April 14, 2026
Via AB Newswire
Topics Artificial Intelligence Derivatives
News headline image
Tuesday's session: gap up and gap down stocks ↗
April 14, 2026
Via Chartmill
News headline image
Stay updated with the stocks that are on the move in today's pre-market session. ↗
April 14, 2026
Via Chartmill
News headline image
These stocks are moving in today's after hours session ↗
April 13, 2026
Via Chartmill
News headline image
Sana Biotechnology and Mayo Clinic Announce Strategic Collaboration Focused on Improving Care in Type 1 Diabetes and Accelerating Development of SC451
April 13, 2026
From Sana Biotechnology, Inc
Via GlobeNewswire
News headline image
Sana Biotechnology Announces Continued Positive Clinical Results Through 14 Months from Type 1 Diabetes Study of Islet Cell Transplantation Without Immunosuppression
March 13, 2026
From Sana Biotechnology, Inc
Via GlobeNewswire
News headline image
Sana Biotechnology Reports Fourth Quarter and Full Year 2025 Financial Results and Business Updates
March 03, 2026
From Sana Biotechnology, Inc
Via GlobeNewswire
News headline image
Sana Biotechnology to Present at March 2026 Investor Conferences
February 23, 2026
From Sana Biotechnology, Inc
Via GlobeNewswire
News headline image
Sana Biotechnology Appoints Brian Piper as Executive Vice President, Chief Financial Officer
February 17, 2026
From Sana Biotechnology, Inc
Via GlobeNewswire
News headline image
Sana Biotechnology to Present at the 44th Annual J.P. Morgan Healthcare Conference
January 07, 2026
From Sana Biotechnology, Inc
Via GlobeNewswire
News headline image
Sana Biotechnology Announces Publication in Nature Biotechnology of in vivo Gene Editing of Human Hematopoietic Stem Cells in Preclinical Models Using the Fusogen Platform
December 08, 2025
From Sana Biotechnology, Inc
Via GlobeNewswire
News headline image
Sana Biotechnology to Present at December 2025 Investor Conferences
November 24, 2025
From Sana Biotechnology, Inc
Via GlobeNewswire
News headline image
Quantum Computer That Could 'Hack Everyone's Crypto': Why Eric Jackson Is Betting On BTQ Technologies As His Next 100-Bagger ↗
November 10, 2025
Via Benzinga
News headline image
Sana Biotechnology Reports Third Quarter 2025 Financial Results and Business Updates
November 06, 2025
From Sana Biotechnology, Inc
Via GlobeNewswire

Frequently Asked Questions

Is Sana Biotechnology, Inc. - Common Stock publicly traded?
Yes, Sana Biotechnology, Inc. - Common Stock is publicly traded.
What exchange does Sana Biotechnology, Inc. - Common Stock trade on?
Sana Biotechnology, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Sana Biotechnology, Inc. - Common Stock?
The ticker symbol for Sana Biotechnology, Inc. - Common Stock is SANA on the Nasdaq Stock Market
What is the current price of Sana Biotechnology, Inc. - Common Stock?
The current price of Sana Biotechnology, Inc. - Common Stock is 2.720
When was Sana Biotechnology, Inc. - Common Stock last traded?
The last trade of Sana Biotechnology, Inc. - Common Stock was at 10/07/26 04:00 PM ET
What is the market capitalization of Sana Biotechnology, Inc. - Common Stock?
The market capitalization of Sana Biotechnology, Inc. - Common Stock is 520.88M
How many shares of Sana Biotechnology, Inc. - Common Stock are outstanding?
Sana Biotechnology, Inc. - Common Stock has 521M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap